<DOC>
	<DOC>NCT01304238</DOC>
	<brief_summary>The purpose of this retrospective registry is to collect data about patients with acute HIT II (Heparin-induced Thrombocytopenia type II) which were treated with Lepirudin, Danaparoid, Argatroban or Fondaparinux. It is a main objective of this registry to mirror the daily routine in this indication in Germany.</brief_summary>
	<brief_title>Retrospective Registry of Patients With Acute Heparin-induced Thrombocytopenia Type II</brief_title>
	<detailed_description />
	<mesh_term>Thrombocytopenia</mesh_term>
	<mesh_term>Fondaparinux</mesh_term>
	<mesh_term>PENTA</mesh_term>
	<mesh_term>Argatroban</mesh_term>
	<mesh_term>Danaproid</mesh_term>
	<mesh_term>Lepirudin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<mesh_term>Dermatan Sulfate</mesh_term>
	<mesh_term>Hirudins</mesh_term>
	<criteria>Acute HIT II (Heparininduced Thrombocytopenia type II), 4TScore Treatment of HIT with Lepirudin, Danaparoid, Argatroban or Fondaparinux</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Retrospective evaluation of patients with acute Heparin-induced Thrombocytopenia type II treated with Fondaparinux</keyword>
</DOC>